Biosciences’ ALD Mary Maxon and Chief Science and Technology Officer Jay Keasling recently attended an event in Washington, D.C., sponsored by the Council on Competitiveness. The briefing on Capitol Hill marked the release of the council’s report, Leverage: Advancing U.S. Bioscience, which captures the outputs of a day-long discussion last year about infrastructure, technology, investment, and talent needed for advancements in U.S. bioscience.
Berkeley Lab Director Announces Biosciences Leadership Transition
In a town hall meeting on June 28, Laboratory Director Mike Witherell announced that Biosciences Associate Lab Director Jay Keasling has agreed to take on an important new role as Chief Science and Technology Officer (CSTO) for the Biosciences Area, and Mary Maxon, currently the principal deputy for Biosciences, will replace Keasling as ALD for Biosciences, effective July 1, 2017.
Keasling to Receive 2017 Amgen Biochemical and Molecular Engineering Award
Associate Laboratory Director for Biosciences Jay Keasling has been selected as the 2017 recipient of the Amgen Biochemical and Molecular Engineering award, to be presented July 19 at the 20th Conference on Biochemical and Molecular Engineering in Newport Beach, Calif. The award, given in memory of metabolic engineering pioneer James E. “Jay” Bailey, recognizes research excellence and leadership.
Energy Secretary Perry Lauds California’s National Labs During China Trip
The Bay Area Council recently traveled to China for a global conference on climate change. The delegation, which included Associate Laboratory Director for Biosciences Jay Keasling, met with US Energy Secretary Rick Perry to discuss the important role of California’s national labs, including Berkeley Lab, in advancing clean energy technology. Perry called California’s labs “crown jewels.”
Keasling Quoted in Nature Article About Biomanufacturing
Jay Keasling, Associate Laboratory Director for Biosciences, was quoted in an article by Nature about engineering tools for cell design for the manufacture of drugs, food and materials. Keasling namely discussed how synthesizing DNA continues to become easier and inexpensive. Read more in Nature.
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Next Page »
Was this page useful?
Send
